BioTech/Drugs - Newark, DE, US
Biosion is a leading "In Global For Global" clinical stage biotechnology company developing innovative biologics to address resistant, relapsed and residual disease for patients worldwide. Established in 2017, Biosion has assembled a world-class team with extensive experience in global biologics development and built an oncology and auto-immune focused pipeline of innovative biologics through its internally-derived proprietary technologies, including the H3 hybridoma platform, SynAbTM synergistic antibody platform, SynTracerTM HT-endocytosis screening, and FlexibodyTM bispecific platforms. Biosion's mission is to discover and develop innovative biologics through the synergy of great science, cutting edge technologies and superior craftmanship for patients worldwide.
Outlook
Google Tag Manager
McAfee
Mobile Friendly
Amazon AWS